| |
| |
|
| Insider
Information: |
Tursi James Patrick |
| Relationship: |
Director |
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
352,117 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$263,375 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
352,117 |
|
|
| Total
Value |
$263,375 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
POZEN Inc |
POZN |
Chief Medical Officer |
2015-10-01 |
30,637 |
2015-10-01 |
0 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Chief Medical Officer |
2018-05-14 |
242,052 |
2016-02-05 |
0 |
Premium* |
|
|
Agile Therapeutics Inc |
AGRX |
Director |
2022-06-09 |
2,066 |
2018-06-08 |
0 |
Premium* |
|
|
Antares Pharma Inc |
ATRS |
EVP, Chief Medical Off... |
2019-06-13 |
45,205 |
2019-06-13 |
0 |
Premium* |
|
|
NeuroBo Pharmaceuticals Inc |
NRBO |
Director |
2023-12-01 |
32,157 |
2023-12-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NRBO |
NeuroBo Pharmaceuticals I... |
Director |
– • – |
2023-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
32,157 |
32,157 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
670 |
2,066 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
24,510 |
55,852 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Director |
– • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
13,393 |
31,342 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
EVP, Chief Medical Officer |
• – – |
2019-06-13 |
4 |
A |
$2.92 |
$131,999 |
D/D |
45,205 |
45,205 |
0 |
- |
|
| AGRX |
Agile Therapeutics Inc |
Director |
– • – |
2018-06-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,949 |
17,949 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2018-05-14 |
4 |
AS |
$0.52 |
$4,882 |
D/D |
(9,348) |
242,052 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2018-03-19 |
4 |
AS |
$1.70 |
$10,115 |
D/D |
(5,950) |
251,400 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2017-10-02 |
4 |
AS |
$2.50 |
$24,918 |
D/D |
(9,960) |
257,350 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
83,192 |
267,310 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2017-03-15 |
4 |
B |
$2.11 |
$10,023 |
D/D |
4,750 |
184,118 |
2.74 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2016-05-20 |
4 |
B |
$3.75 |
$37,500 |
D/D |
10,000 |
179,368 |
2.74 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2016-05-16 |
4 |
B |
$3.79 |
$17,037 |
D/D |
4,500 |
169,368 |
2.74 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2016-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
47,368 |
164,868 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2016-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
86,863 |
117,500 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Chief Medical Officer |
• – – |
2016-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
30,637 |
30,637 |
0 |
- |
|
| POZN |
POZEN Inc |
Chief Medical OfficerOfficer |
• – – |
2015-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,500 |
|
- |
|
| POZN |
POZEN Inc |
Chief Medical Officer |
• – – |
2015-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,137 |
30,637 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
